Reports say that a drug using iPS cells is expected to proceed to the first regulatory application, and attention is focused on developments in the global development race, including Japan. This introduces coverage related to a special feature on Nikkei Plus 9.
Reports say that a drug using iPS cells is expected to proceed to the first regulatory application, and attention is focused on developments in the global development race, including Japan.
The subject was covered as part of BS TV Tokyo's Nikkei News special feature, Nikkei Plus 9, with content from the 30 May 2024 broadcast subsequently distributed on YouTube.
The situation is being closely watched as further updates are awaited, with views expressed that technological development and regulatory trends will be focal points.